Shanghai, China

Pingzheng Zhou


 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Pingzheng Zhou in Potassium Channel Agonists

Introduction

Pingzheng Zhou is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target potassium channels. His work focuses on creating effective treatments for nervous system diseases.

Latest Patents

One of Pingzheng Zhou's key patents is titled "Compound as KCNQ potassium channel agonist, preparation method therefor and use thereof." This invention provides compounds with a specific structure that can be used as KCNQ potassium channel agonists. These compounds are designed for the preparation of medicines aimed at treating nervous system diseases. Compared to the prior art compound retigabine, Zhou's invention demonstrates equal or superior therapeutic effects, along with advantages in synthesis, storage, and stability against oxidative deterioration. He holds 1 patent related to this innovative work.

Career Highlights

Pingzheng Zhou is affiliated with the Chinese Academy of Sciences, where he conducts his research and development activities. His work has garnered attention for its potential impact on medical treatments for various neurological conditions.

Collaborations

Zhou collaborates with esteemed colleagues such as Fajun Nan and Min Li, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Pingzheng Zhou's contributions to the field of potassium channel agonists represent a significant advancement in the treatment of nervous system diseases. His innovative approach and dedication to research continue to pave the way for future medical breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…